NuVasive Inc. (NSDQ:NUVA) said yesterday that it submitted its SpineTrack registry quality performance data to the Centers of Medicare & Medicaid Services. The data was submitted on behalf of healthcare providers at Southern Oregon Neurosurgical & Spine Associates (SONSA) for CMS’s merit-based incentive payment system, the San Diego-based company said. As a result of the submittal, […]
Nuvasive
Is the orthopedic device space in the midst of a robot revolution?
Stryker’s success with its Mako robot-assisted surgery platform has other orthopedic device companies hastening to enter the space. The big question is whether long-term outcomes will justify the expensive technology. More than five years after spending $1.7 billion to acquire Mako Surgical, Stryker is leading the way bringing robot-assisted surgery to the orthopedic space. The […]
NuVasive shares steady on Q1 earnings beat
Shares in NuVasive Inc. (NSDQ:NUVA) are steady in after hours trading today after the medical device maker posted first quarter 2019 earnings that beat expectations on Wall Street. The San Diego-based company posted profits of approximately $9.4 million, or 18¢ per share, on sales of $274.8 million for the three months ended March 31, seeing a […]
NuVasive touts results of PEEK implant study
NuVasive (NSDQ:NUVA) today announced the results of a study that showed its Cohere porous polyetheretherketone (PEEK) implant improved early outcomes over structural allograft and smooth PEEK in anterior cervical discectomy and fusion (ACDF) procedures. In the study of 167 patients with degenerative cervical disc disease, those who underwent ACDF using Cohere porous PEEK exhibited significant […]
NuVasive launches X360 lateral single-position surgery device
NuVasive Inc. (NSDQ:NUVA) said yesterday that it launched its X360 system intended for lateral single-position surgery in the U.S. The newly launched X360 system features improvements intended to accommodate advanced techniques and technologies for enhanced operating room workflow and efficiency, the San Diego-based company said. The system also features integration with NuVasive’s Pulse surgical automation platform […]
Ex-NuVasive CEO Lucier to head new M&A firm Corza Health
Recently departed NuVasive (NSDQ:NUVA) CEO Gregory Lucier will lead a new company formed to acquire medtech and life sciences firms and assets. Lucier, 54, is partnering with Chicago-based private equity firm GTCR to form the new company, Corza Health, in San Diego. GTCR holds stakes in Regatta Medical, which owns laser micro manufacturer Resonetics and Sotera Health along with life sciences, technology, and […]
NuVasive shares rise on Q4, 2018 EPS beat
Shares in NuVasive Inc. (NSDQ:NUVA) have risen slightly today after the medical device maker beat earnings per share expectations on Wall Street with its fourth quarter and full year 2018 earnings report. The San Diego-based company posted profits of approximately $12.2 million, or 23¢ per share, on sales of $288.3 million for the three months ended […]
NuVasive wins FDA, CE Mark for Precice internal bone transport system
NuVasive Inc. (NSDQ:NUVA) said today that it won FDA 510(k) clearance and CE Mark clearance in the European Union for its Precice bone transport system. The San Diego, Calif.-based company touted the system as the only all-internal system indicated for use in segmental bone loss treatment in the tibia and femur resulting from trauma or infection. […]
Alphatec touts stay in NuVasive patent infringement case
Alphatec (NSDQ:ATEC) said today that a U.S. District Court granted a stay in a the patent litigation between it and competitor NuVasive (NSDQ:NUVA) while the U.S. Patent and Trademark Office considers recently filed challenges from Alphatec. The Carlsbad, Calif.-based company said that the stay, which was agreed to by both companies, was granted by the U.S. District […]
Report: Smith & Nephew eyeing $3B NuVasive acquisition
Smith & Nephew (NYSE:SNN) is in discussions to pick up spine-focused medtech developer NuVasive Inc. (NSDQ:NUVA) in a deal that could be worth more than $3 billion, according to a report from the Financial Times released late last week. The companies have not officially commented on the possible acquisition. NuVasive has a market valuation of approximately $2.6 […]
Abiomed jumps on fiscal Q3 prelims, raised outlook | Wall Street Beat
Abiomed (NSDQ:ABMD) shares got a jump today from its preliminary fiscal third-quarter numbers and an improved outlook for the rest of its fiscal year. The Danvers, Mass.-based heart pump maker said it expects to post fiscal Q3 sales of roughly $200.6 million, representing a 30.3% increase over its fiscal Q3 top line. Abiomed also raised […]